David Lavergne
Overview
Explore the profile of David Lavergne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nicol M, Kitzinger C, Baudet M, Faradji A, Pezel T, Lavergne D, et al.
Amyloid
. 2024 Sep;
31(4):318-325.
PMID: 39319571
Background: This study aimed to assess the prognostic value of cardiac magnetic resonance (CMR) variables and compare them with biological and echocardiographic markers in patients with AL cardiac amyloidosis (CA)....
2.
Ito Y, Marouf A, Kogure Y, Koya J, Lievin R, Bruneau J, et al.
Cancer Res
. 2024 Apr;
84(13):2181-2201.
PMID: 38657099
Extranodal NK/T-cell lymphoma (ENKTCL) is an Epstein-Barr virus (EBV)-related neoplasm with male dominance and a poor prognosis. A better understanding of the genetic alterations and their functional roles in ENKTCL...
3.
Chaubard S, Marouf A, Lavergne D, Lemonnier F, Rossignol J, Clavert A, et al.
Br J Haematol
. 2023 Feb;
201(4):673-681.
PMID: 36799516
Extranodal NK/T-cell lymphoma, nasal type is a rare and aggressive form of lymphoma, historically associated with poor prognosis. We report here the results of a retrospective multi-centre study evaluating the...
4.
Bender S, Javaugue V, Saintamand A, Ayala M, Alizadeh M, Filloux M, et al.
Blood
. 2020 Apr;
135(20):1750-1758.
PMID: 32243509
Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is a rare multisystem disease resulting from an underlying plasma cell (PC) dyscrasia. The pathophysiology of the disease remains unclear,...
5.
Roussel M, Merlini G, Chevret S, Arnulf B, Stoppa A, Perrot A, et al.
Blood
. 2020 Feb;
135(18):1531-1540.
PMID: 32108228
Daratumumab is a human monoclonal antibody targeting CD38, an antigen uniformly expressed by plasma cells in multiple myeloma and light-chain amyloidosis (AL). We report the results of a prospective multicenter...
6.
Wang X, Kim T, Hegde S, Hoffman D, Benda N, Franklin E, et al.
Appl Clin Inform
. 2019 Sep;
10(4):693-706.
PMID: 31533171
Background: Hospital emergency departments (EDs) are dynamic environments, involving coordination and shared decision making by staff who care for multiple patients simultaneously. While computerized information systems have been widely adopted...
7.
Rech J, Arnulf B, de Margerie-Mellon C, Talbot A, Malphettes M, Vignon M, et al.
Am J Hematol
. 2019 Aug;
94(11):1214-1226.
PMID: 31396978
Lower-respiratory-tract (LRT) amyloidosis has rarely been investigated. Our study presents characteristics, outcomes and survival of LRT amyloidosis. This multicenter retrospective study, from 1995 to 2017, included 73 patients with amyloidosis...
8.
Nicol M, Baudet M, Brun S, Harel S, Royer B, Vignon M, et al.
Eur Heart J Cardiovasc Imaging
. 2019 Jul;
21(5):542-548.
PMID: 31292624
Aims: Early diagnosis of cardiac involvement is a key issue in the management of AL amyloidosis. Our objective was to establish a diagnostic score of cardiac involvement in AL amyloidosis...
9.
Marek J, Palecek T, Magne J, Lavergne D, Boulogne C, Fadel B, et al.
Echocardiography
. 2018 Sep;
35(11):1755-1763.
PMID: 30247786
Background: Fabry cardiomyopathy (FC) and light-chain amyloid cardiomyopathy (AL) present with concentric left ventricular (LV) hypertrophy/remodeling and diastolic rather than systolic dysfunction. Direct comparisons are difficult due to rarity and...
10.
Mohty D, Petitalot V, Magne J, Fadel B, Boulogne C, Rouabhia D, et al.
J Cardiol
. 2018 Aug;
72(4):368.
PMID: 30122209
No abstract available.